Best of Oncology East 2021

bookLearning Objectives

The Best of Oncology East 2021 Conference is a digital meeting and will be held on Friday, November 19, 2021.  Chaired by Dr. Scott Berry, Dr. Suneil Khanna and Dr. Dorothy Lo, this meeting highlights the top 3-4 most clinically relevant achievements of 2021 for several tumour sites and will incorporate several multi-disciplinary event sessions addressing: radiation oncology, surgical oncology and support care.  Faculty will be drawn from some of the most influential oncologists across the country. 
  • To discuss the pivotal oncology trials presented in the different disease sites
  • To review the current standard of care for key malignancies
  • To discuss the current controversies in the management of specific cancers



Friday, November 19, 2021

Local Time

  • Timezone: America/New_York
  • Date: Friday, November 19, 2021
  • Time: 8:15 am - 3:15 pm


Registration is complimentary for healthcare professionals and can be completed below.

Industry representatives (both sponsor and non-sponsor) can register by contacting Laura Davidson at

Book Event

1 Ticket selected.

Available Tickets: Unlimited

The ticket is sold out. You can try another ticket or another date.

Scientific Agenda

8:15 am – 9:00 am EDT

AZ Breakfast Symposia: Targeted therapies in 2021: Managing Early and Late Stage EGFR+ NSCLC – Dr. Parneet Cheema with panelist, Dr. Diana Ionescu

9:00 am – 9:15 am EDT

Welcome Address by Chairs – Dr. Scott Berry, Dr. Dorothy Lo, & Dr. Suneil Khanna

9:15 am – 9:45 am EDT

Lung Cancer – Dr. Jeff Rothenstein

9:45 am – 10:25 am EDT

Special Session:   What Medical Oncologists need to know about New Molecular Diagnostic – Dr. Brandon Sheffield

10:25 a.m. – 10:35 a.m. EDT


10:35 am – 11:05 am EDT

Colorectal GI Cancer – Dr. Rachel Goodwin

11:05 am – 11:35 am EDT

Gastroesophageal Cancer – Dr. Elena Elimova

11:35 am – 12:05 pm EDT

Pancreatic, Biliary, and HCC – Dr. Ravi Ramjeesingh

12:05 pm – 12:35 pm EDT


12:35 pm – 1:20 pm EDT

BMS Lunch Symposia:  IO Treatment for RCC – How we got to where we are – Dr. Christian Kollmannsberger with panelist Dr. Aly-Khan Lalani

1:20 pm – 1:50 pm EDT

Prostate Cancer – Dr. Sebastien Hotte

1:50 pm – 2:20 pm EDT

Non-Prostate GU Cancer – Dr. Aly-Khan Lalani

2:20 pm – 2:30 pm EDT


2:30 pm – 3:00 pm EDT

Breast Cancer – Dr. Mark Clemons

3:00 pm – 3:15 pm EDT

 Closing Remarks by Chairs – Dr. Scott Berry, Dr. Dorothy Lo, & Dr. Suneil Khanna

personAbout the Faculty

Dr. Scott Berry

Dr. Scott Berry

Conference Chair

Dr. Scott Berry is a medical oncologist and Professor and Department Head in the Queen’s University Department of Oncology.He is the Cancer Program Medical Director at the Cancer Centre of Southeastern Ontario at the Kingston Health Sciences Centre.

Dr. Berry is an active participant in clinical research in GI cancer. He is the Co-Chair of the GI Disease Site Group of the CCO Program in Evidence Based Care.

Dr. Berry loves teaching, has won several teaching awards and is a past Chair of the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology.

His other academic interest is the bioethical issues surrounding the care of people with cancer, in particular the ethical issues surrounding funding new and expensive cancer medications. Dr. Berry has a Master’s degree in Bioethics from the University of Toronto. He is the former ethics advisor to the pan-Canadian Oncology Drug Review and has served on the ASCO Ethics Committee.

Suneil Khanna

Dr. Suneil Khanna

Conference Chair

Dr. Suneil Khanna is a Medical Oncologist at the Mackenzie Health Hospital in Richmond Hill. He completed his medical school at the University of Alberta, residency training at the University of Calgary, and Fellowship Training at Sunnybrook Health Sciences Centre, specializing in Gastrointestinal and Thoracic malignancies. He has a special interest in clinical trials and medical education, and is the co-chair of the COMET Education Committee and a planning committee member for the annual MAGIC meeting.

Dorothy Lo
Dr. Dorothy Lo

Conference Chair

Dr. Dorothy Lo graduated from U of T Faculty of Medicine, McMaster Internal Medicine Programme, and medical oncology residency at U of T. During residency, Dr. Lo started studies in MHSc-Health Administration at U of T and graduated in 2008. She contributed to research projects and publications in cancer diagnostic assessment programs as part of residency training and as part of her internship at CCO.

As a staff medical oncologist at SJHC since 2007, Dr. Lo has served as the Head of the Division of Haematology & Oncology since 2013. At SJHC, she has been the site Principle investigator for five clinical trials.

In the oncology community, Dr. Lo has been active as the co-chair of education for COMET since 2008. Dr. Lo previously served as the Secretary and then VP of the Haematology & Oncology Section of the OMA. She has an academic affiliation with U of T as an Adjunct Clinical Lecturer. Since 2015, Dr. Lo has been the Chair of the Partnership Series which focuses on building Communities of Practice to improve access and collaboration in cancer care. Outcomes data from the Partnership Series was presented at CAMO 2017 and published as two separate articles in 2018.


For sponsorship-related inquiries, please contact Bernadette Gregoris at

Platinum Sponsors

Amgen Oncology
Bristol Myers Squibb logo
AstraZeneca logo

Gold Sponsors

Merck logo
Roche logo
Ipsen logo

Silver Sponsors

Eisai logo
Astellas logo

Bronze Sponsors

Lilly logo